Gainers:
Adjustable-firmness mattresses maker Select Comfort Corp. (SCSS), Wednesday said its profit for the first quarter more than doubled from last year. The company also raised its fiscal year 2011 earnings guidance, based on its solid performance. Following the news, the company gained more than 21 percent in after-hours trade in the Nasdaq.
F5 Networks Inc. (FFIV) gained nearly 13 percent in after-hours trade in the Nasdaq, as it posted a 68 percent growth in its second-quarter profit. The company also provided third quarter outlook, which is indicated to be in-line with the Street estimate.
Student lender SLM Corp. (SLM), commonly known as Sallie Mae, posted a better-than-expected profit for the first quarter. The company has also reinstated its dividend, and approved a $300 million share buyback program. SLM gained more than 5 percent in after-hours trading in the NYSE.
Restaurant chains operator Yum! Brands Inc. (YUM) gained more than 6 percent in the extended-hours trading in the NYSE, as it reported a 9.5 percent growth in profit for the first quarter.
Qualcomm Inc. (QCOM) reported that its profit for the second quarter increased by 29 percent over last year. The company also raised its outlook for fiscal 2011. Following the news, the company gained more than 4 percent in the extended-hours trading in the Nasdaq.
Losers:
Restaurant chain Chipotle Mexican Grill Inc. (CMG) said its profit for the first quarter improved from a year ago, as revenues climbed over 24 percent, helped by new restaurants and an impressive comparable restaurant sales growth.
Though Chipotle Mexican's earnings and revenue for the quarter came in ahead of Street estimates, restaurant level operating margins declined, sending its shares down over 3 percent in after hours trade on the NYSE.
Biopharmaceutical company Gilead Sciences Inc. (GILD) lost more than 3 percent in the after-hours trading in the Nasdaq, as it posted a 24 percent drop in its first-quarter profit.
Amgen Inc. (AMGN) said its profit for the first quarter declined by 3 percent from last year, due to lower sales of its major drugs, including Aranesp and Epogen, and higher expenses. Quarterly adjusted eanrings, however, came well ahead of the Street expectations, as did revenue. Looking ahead, the company reaffirmed its outlook for fiscal 2011. The company lost more than 2 percent in after-hours in the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.